SCOTTSDALE, Ariz., Jan. 24, 2024 /PRNewswire/ -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, has been named the top franchise in chiropractic services by Entrepreneur Magazine's Franchise 500, the world's first and most comprehensive franchise ranking. The Joint ranked No. 83 on the 2024 list, and has also been named a 2023 top franchise for veterans. "It is a great honor to start 2024 by being named the top chiropractic franch ...

公司业绩 - The Joint Corp. 2023年全年系统销售额增长12%，与2022年相比[1] - The Joint Corp. 2023年全年进行了1360万次患者就诊，相比2022年的1220万次[2] - The Joint Corp. 2023年全年新增患者93.2万人，相比2022年的84.5万人[2] - The Joint Corp. 2023年全年系统销售额增长12%，相比2022年的21%[2] - The Joint Corp. 2023年全年同店销售额增长4%，相比2022年的9%[2] - The Joint Corp. 2023年共开设了114家新诊所，使年末总诊所数量达到935家[1] - The Joint Corp. 2023年12月31日共有800家诊所，相比2022年的712家[3] - The Joint Corp. 2023年12月31日共有135家诊所，相比2022年的126家[3] 公司发展 - The Joint Corp. CEO Peter D. Holt表示，公司团队致力于通过定期和经济实惠的脊椎按摩护理提高生活质量，尽管面临持续的宏观经济挑战，但在2023年实现了患者数量增长和持续增长[4] - The Joint Corp. CEO Peter D. Holt和CFO Jake Singleton将于2024年3月7日下午5:00举行电话会议，讨论第四季度和2023年年底的财务业绩[5] 公司背景 - The Joint Corp. 是全国最大的脊椎按摩诊所运营商、管理者和特许经营者，通过The Joint Chiropractic网络管理和特许经营超过900家诊所，每年接待超过1300万次患者就诊[6] - The Joint Corp. 在一些州是诊所的特许经营者和运营者，在其他州提供管理服务给专业脊椎按摩诊所[7]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ☒ EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ☐ EXCHANGE ACT OF 1934 For the transition period from __________________ to _________________ Commission file number: 001-36724 The Joint Corp. (Exact name of registrant as specified in its charter) Delaware ...

财务数据和关键指标变化 - 系统销售额增长8%至1.193亿美元 [15] - 同店销售额保持平稳,增长0% [31] - 收入增长11%至2950万美元 [32] - 毛利润增长11%至260万美元 [33] - 调整后EBITDA为290万美元 [15][36] - 净亏损71.6万美元,每股亏损0.05美元 [35] 各条业务线数据和关键指标变化 - 特许经营业务收入增长9%至1160万美元 [32] - 公司拥有或管理的诊所收入增长13%至1790万美元 [32] 各个市场数据和关键指标变化 - 新患者数量下降,影响了同店销售 [111][112][113] - 会员转化率保持在50%以上,优于疫情前水平 [112] - 会员流失率下降至11%,优于疫情前水平 [112] 公司战略和发展方向及行业竞争 - 公司将把大部分公司拥有或管理的诊所转让给特许经营商 [13][41][47] - 保留部分高表现诊所,用于测试价格调整、新会员计划等 [18] - 专注于特许经营网络的发展,提高特许经营商的业绩 [22][47] - 行业市场空间大,公司在特许经营网络和品牌知名度方面具有先发优势 [48][49][50][51][52] 管理层对经营环境和未来前景的评论 - 宏观经济不确定性和成本压力影响了公司自营诊所的业绩 [13] - 新患者数量下降与消费者支出受到宏观经济因素影响有关 [69][70][71][112][113] - 公司正采取措施提高新患者数量,包括优化营销投放和提升客户体验 [105][106][107] - 公司对未来前景保持乐观,认为行业增长前景良好 [48][49][50][51][52] 问答环节重要的提问和回答 问题1 **Richard Magnusen 提问** 询问不同诊所群体的业绩趋势以及最新群体的表现 [56][57][59] **Jake Singleton 回答** 公司不会进一步细分数据,但总体同店销售平稳不理想,公司正采取措施提高新患者数量 [58][59] 问题2 **George Kelly 提问** 询问公司是否面临行业性问题,而不是自身的新患者获取问题,以及消费者支出情况 [69][70][71][72] **Peter Holt 回答** 公司认为新患者下降与消费者支出受宏观经济因素影响有关,而不是行业竞争导致 [72][73][74] 问题3 **Jeremy Hamblin 提问** 询问公司如何确定诊所的估值和定价,以及预期的买家类型 [83][84][87][88][89][90] **Peter Holt 和 Jake Singleton 回答** 公司将根据各诊所的具体表现和多种估值方法确定定价,既包括医生买家也包括有经验的企业家买家 [84][85][87][88][89][90]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ☒ EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ☐ EXCHANGE ACT OF 1934 For the transition period from __________________ to _________________ Commission file number: 001-36724 The Joint Corp. (Exact name of registrant as specified in its charter) Delaware (Stat ...

The Joint Corp. (NASDAQ:JYNT) Q2 2023 Earnings Conference Call September 13, 2023 5:00 PM ET Company Participants Kirsten Chapman - Managing Director and Principal, HA Investor Relations Peter Holt - President and Chief Executive Officer Jake Singleton - Chief Financial Officer Conference Call Participants Richard Magnusen - B. Riley FBR George Kelly - ROTH MKM Anthony Vendetti - Maxim Group Operator Good afternoon, and welcome to the preliminary Q2 2023 Financial Review for The Joint Conference Call. All p ...

业绩总结 - The Joint Corp. Q2 2023系统销售额同比增长13%[5] - 新开设26家诊所，总计890家诊所[6] - 2022年区域开发商销售的67%特许经营许可证[7]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ☒ EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ☐ EXCHANGE ACT OF 1934 For the transition period from __________________ to _________________ Commission file number: 001-36724 The Joint Corp. (Exact name of registrant as specified in its charter) Delaware (Sta ...

The Joint Corp. (NASDAQ:JYNT) Q4 2022 Earnings Conference Call March 9, 2023 5:00 PM ET Company Participants David Barnard - LHA Investor Relations Peter Holt - President and CEO Jake Singleton - CFO Conference Call Participants Jeff Van Sinderen - B. Riley FBR Anthony Vendetti - Maxim Group George Kelly - ROTH Capital Partners Brooks O'Neil - Lake Street Capital Markets Linda Bolton Weiser - DA Davidson Operator Good day, and welcome to The Joint Fourth Quarter 2022 Financial Results Conference Call. [Oper ...

Q4 2022 Financial Results As of December 31, 2022 | Reported on March 9, 2023 Safe Harbor Statements Certain statements contained in this presentation are "forward-looking statements" about future events and expectations. Forward-looking statements are based on our beliefs, assumptions and expectations of industry trends, our future financial and operating performance and our growth plans, taking into account the information currently available to us. These statements are not statements of historical fact. ...